PDPN increases tumor cell clonality, EMT, migration, invasion, metastasis and inflammation in tumors including glioma, squamous cell carcinoma, mesothelioma and melanoma and is considered a potential tumor biomarker and therapy target (166). Here, PDPN is linked to squamous cell carcinoma.